ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

SLGL Sol Gel Technologies Ltd

0.80
0.079 (10.96%)
May 31 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 46,575
Bid Price 0.88
Ask Price 0.96
News -
Day High 0.82

Low
0.6311

52 Week Range

High
4.0498

Day Low 0.7103
Share Name Share Symbol Market Stock Type
Sol Gel Technologies Ltd SLGL NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.079 10.96% 0.80 19:00:00
Open Price Low Price High Price Close Price Previous Close
0.758 0.7103 0.82 0.80 0.721
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
303 46,575 US$ 0.801967 US$ 37,352 - 0.6311 - 4.0498
Last Trade Type Quantity Price Currency
15:00:00 100 US$ 0.80 USD

Sol Gel Technologies Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
22.29M 27.86M - 1.61M -27.24M -0.98 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Sol Gel Technologies News

Date Time Source News Article
5/28/202406:17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/28/202406:00GlobeNewswire Inc.Sol-Gel Announces Receipt of Nasdaq Minimum Price Notice
5/20/202415:05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]
5/20/202406:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/20/202406:00GlobeNewswire Inc.Sol-Gel Reports First Quarter 2024 Financial Results and..
5/16/202405:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/16/202405:00GlobeNewswire Inc.Sol-Gel and Beimei Pharma Announce an Asset Purchase..
4/01/202406:00GlobeNewswire Inc.Sol-Gel’s Collaboration Partner First-to-File ANDA Drug..
3/13/202406:00GlobeNewswire Inc.Sol-Gel Reports Full-Year 2023 Financial Results and..
3/06/202407:29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/29/202407:07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/23/202405:49Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SLGL Message Board. Create One! See More Posts on SLGL Message Board See More Message Board Posts

Historical SLGL Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.800.82140.71030.775497715,4730.000.00%
1 Month0.870.890.63110.747567338,100-0.07-8.05%
3 Months1.081.110.63110.876587233,257-0.28-25.93%
6 Months1.281.57540.63111.0331,029-0.48-37.50%
1 Year3.504.04980.63111.5121,444-2.70-77.14%
3 Years10.3214.500.63115.2118,049-9.52-92.25%
5 Years8.4926.520.63119.1027,917-7.69-90.58%

Sol Gel Technologies Description

Sol-Gel Technologies Ltd is a clinical-stage specialty pharmaceutical company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.

Your Recent History